Condition: End Stage Kidney Disease · Fibrosis Myocardial · Sponsor: University of Leicester
There are currently no good ways of measuring levels of scarring in the hearts of patients with advanced kidney disease and patients on dialysis, although recent research has shown a new cardiac MRI technique, called native T1 mapping, may provide a solution to this. To assess the accuracy of this novel technique in dialysis patients, it is essential to undertake a study which compares native T1 mapping to actual levels of scarring in the hearts of patients on dialysis.
This description comes directly from the study's public registry record.
James Burton, DM, FRCP · +44 (0)116 2588043 · jb343@le.ac.uk
Matthew Graham-Brown, MBChB, MRCP · +44 (0)116 2588043 · mgb23@le.ac.uk
Always discuss trial participation with your own doctor first.
| University Hospitals of Leicester NHS Trust | Leicester, Leicestershire, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03586518